Treatment of Acute Pyelonephritis With Gram Negative Strains in Infants and Children Less Than 3 Years Old
NCT00136656 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 700
Last updated 2009-02-12
Summary
The purpose of this study is to demonstrate the equivalence of the therapeutic efficacy of cefixime by mouth (PO) 10 days (d) and ceftriaxone intravenous route(IV) 4d followed by cefixime PO 6d on renal scars 6 months after a first acute pyelonephritis episode.
The investigators hypothesize that treatment with cefixime PO will allow no more renal scars than intravenous route (IV) treatment of pyelonephritis in infants and children less than 3 years old, 6 months after the first episode. If it is true, treatment will no longer need hospitalisation and the advantages for children, families and the health system will be very important.
Conditions
- Pyelonephritis
Interventions
- DRUG
-
antibiotic
cephalosporine by oral route : cefixime
- DRUG
-
antibiotics
cephalosporine : ceftriaxone by intra venous route and cefixime by oral route
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
CHERON GERARD, MD · Hôpital Necker Enfants Malades Assistance Publique Hôpitaux de Paris - René Descartes University Paris 5
-
CHEVALLIER BERTRAND, MD · Ambroise Paré Hospital, Assistance Publique Hôpitaux de Paris
-
GAJDOS VINCENT, MD · Antoine Béclère Hospital Assistance Publique Hôpitaux de Paris
-
LABRUNE PHILIPPE, MD · Antoine Béclère Hospital Assistance Publique Hôpitaux de Paris
-
GRIMPREL EMMANUEL, MD · Trousseau Hospital AP HP
-
DESCHENES GEORGES, MD · TROUSSEAU HOSPITAL AP-HP
-
SERGENT ALINE, MD · TROUSSEAU HOSPITAL AP-HP
-
VAYLET CLAIRE, MD · TROUSSEAU HOSPITAL AP-HP
-
BADER MEUNIER BRIGITTE, MD · BICETRE HOSPITAL AP-HP
-
GUIGONIS VINCENT, MD · DUPUYTREN HOSPITAL CHU LIMOGES
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Month
- Max Age
- 3 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-07-31
- Primary Completion
- 2008-06-30
- Completion
- 2009-02-28
Countries
- France
Study Locations
More Related Trials
-
Pharmacological Study of High Doses of Ceftriaxone in Meningitidis
NCT01745679 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants.
NCT04126031 ·Status: TERMINATED ·Phase: PHASE2
-
A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age
NCT01026636 ·Status: COMPLETED ·Phase: PHASE1
-
Ceftriaxone as Home IV for Staph Infections
NCT04141787 ·Status: UNKNOWN ·Phase: PHASE4
-
Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age
NCT05856227 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia
NCT01602874 ·Status: WITHDRAWN ·Phase: PHASE3
-
Population Pharmacokinetics of Amikacin in Neonates
NCT04867135 ·Status: COMPLETED
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis
NCT06672978 ·Status: RECRUITING ·Phase: PHASE2
-
Antibiotic Stewardship to Prevent Early Sepsis in Preterm Infants
NCT06930911 ·Status: ACTIVE_NOT_RECRUITING
-
Oral vs Initial Intravenous Antibiotic Treatment of Urinary Tract Infections in Children: a RCT
NCT00161330 ·Status: TERMINATED ·Phase: PHASE3
-
Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children
NCT04535661 ·Status: RECRUITING
-
Management of Early Onset Neonatal Septicaemia: Selection of Optimal Antibacterial Regimen for Empiric Treatment
NCT00487019 ·Status: COMPLETED
-
PCR Technic Evaluation in the Microbial Diagnostic of Septicemia in Hemodialysis Patients With Catheter.
NCT04026035 ·Status: COMPLETED
-
Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia
NCT03439124 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia
NCT00914888 ·Status: WITHDRAWN ·Phase: PHASE3
-
Resistant Bacteria in Children in France
NCT06036628 ·Status: COMPLETED
-
Prolonged Infusion Cefepime and Nosocomial Infections
NCT02568800 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen
NCT00609375 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Label Study to Describe the Pharmacokinetics of Cefazolin in Preterm Neonates
NCT00850122 ·Status: COMPLETED ·Phase: PHASE1
-
Oral-only Antibiotics for Bone and Joint Infections in Children
NCT04563325 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease
NCT01030731 ·Status: COMPLETED ·Phase: PHASE1
-
Individualized Precision Therapy With Ceftobiprole Guided by PK/PD in Geriatric Populations
NCT07127185 ·Status: NOT_YET_RECRUITING
-
Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.
NCT00555061 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia
NCT00621504 ·Status: COMPLETED ·Phase: PHASE3
-
Crossover Study to Compare the Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone Administration
NCT02561442 ·Status: COMPLETED ·Phase: PHASE2/PHASE3